Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
This is a double blinded, randomized, placebo controlled clinical trial of 40 participants
with pulmonary sarcoidosis.
Primary Objective: To assess the steroid-sparing efficacy and safety of oral metformin
therapy in participants with confirmed progressive pulmonary sarcoidosis for participants
with steroid dependent disease.